Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/c mice

American Journal of Tropical Medicine and Hygiene

Volumn 54, Issue 2, 1996, Pages 178-184

  Almeida, Roque P ^a   Barral Netto, Manoel ^a   De Jesus, Amelia M R ^a   De Freitas, Luis A R ^b   Carvalho, Edgar M ^a   Barral, Aldina ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; PROTOZOON ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; DISEASE COURSE; FEMALE; GRANULOMA; HUMAN; LEISHMANIA; MACROPHAGE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; SKIN LEISHMANIASIS; TISSUE INJURY; VISCERAL LEISHMANIASIS;

ANIMALIA; LEISHMANIA AMAZONENSIS; PROTOZOA;

EID: 0029917084     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.54.178     Document Type: Article

References (26)

1. Barral A, Pedral-Sampaio D, Grimaidi G Jr, Momem H, McMahon-Pratt D, Ribeiro de Jesus A, Almeida RP, Badaro R, Barral-Netto M, Carvalho EM, Johnson WD Jr, 1991. Leishmania amazonensis is implicated in the whole spectrum of human clinical leishmaniasis. Am J Trop Med Hyg 44: 536-546.
2. Barral A, Badaro R, Barral-Neto M, Grimaidi G Jr, Momem H, Carvalho EM, 1986. Isolation of Leishmania mexicana amazonensis from the bone marrow in a case of American visceral leishmaniasis. Am J Trop Med Hyg 35: 732-734.
3. Sampaio RN, Marsden PD, Llanos-Cuentas EA, Cuba CC, Grimaldi G Jr, 1985. Leishmania mexicana amazonensis isolated from a patient with fatal mucosal leishmaniasis. Rev Soc Bras Med Trop 18: 273-274.
4. Magill N, Grogl M, Gasser RA, Wellington S, Oster CN, 1993. Viscerotropic leishmaniasis caused by Leishmania tropica in soldiers returning from Operation Desert Storm. N Eng J Med 328: 1383-1387.
5. Andrade ZA, Reed SG, Roters SB, Sadigursky M, 1984. Immunopathology of experimental cutaneous leishmaniasis. Am J Pathol 114: 137-148.
6. Shaw BA, Grayson JB, Petersen EA, 1987. Experimental murine infection with the diffuse cutaneous leishmaniasis strain, Isabel. Ann Trop Med Parasitol 81: 9-14.
7. Barral-Netto M, de Freitas LAR, Andrade ZA, 1987. Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c Mice. Am J Pathol 127: 271-277.
8. Grimaldi G Jr, David I, McMahon-Pratt D, 1987. Identification of new world leishmaniasis species characterized by serodema analysis using monoclonal antibodies. Am J Trop Med Hyg 36: 270-287.
9. Badaro R, Reed SG, Barral A, Orge G, Jones TC, 1986. Evaluation of the micro enzyme-linked immunoabsobent assay (ELISA) for antibodies in American visceral leishmaniasis: antigen selection for detection of infection-specific responses. Am J Trop Med Hyg 35: 72-78.
10. Perez H, Labrador F, Torrealba JW, 1979. Variations in the response of five strains of mice to Leishmania mexicana. Int J Parasitol 9: 27-31.
11. Nassen M, Modabber FZ, 1979. Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major. Infect Immun 26: 611-614.
12. Leclerc C, Modabber F, Deriaud E, Chedid L, 1981. Systemic infection of Leishmania tropica (major) in various strains of mice: (a re-evaluation of the concept of dermatotropism). Trans R Soc Trop Med Hyg 75: 851-854.
13. Liew FY, Howard JG, Hale C, 1984. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt 1+2-T cells that do not mediate cutaneous DTH. J Immunol 132: 456-461.
14. Scott P, Pearce E, Natovitz P, Sher A, 1987. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble promastigote extract. J Immunol 139: 221-227.
15. Scott P, Pearce E, Natovitz P, Sher A, 1987. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and non-protective subfractions of a soluble promastigotc extract. J Immunol 139: 3118-3125.
16. Badaro R, Falcoff E, Badaro FS, Carvalho EM, Pedral-Sampaio D, Barral A, Carvalho JS, Barral-Netto M, Brandeley M, Silva L, Bina JC, Teixeira R, Falcoff F, Rocha H, Ho J, Johnson WD Jr, 1990. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med 322: 16-21.
17. Scott P, Farrel JP, 1982. Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice. Am J Trop Med Hyg 31: 230-238.
18. Kahl LP, Byram JE, David JR, 1990. Leishmania (Viannia) braziliensis isolated from cutaneous and mucosal lesions of patients residing in Tres Bracos, Bahia, Brazil differ in virulence for the golden hamster. Trans R Soc Trop Med Hyg 84: 783-784.
19. Kahl LP, Byram JE, David JR, Comerford SA, Von Lichtenberg F, 1991. Leishmania (Viannia) brazihensis comparative pathology of golden hamsters infected with isolates from cutaneous and mucosal lesions of patients residing in Tres Bracos, Bahia, Brazil. Am J Trop Med Hyg 44: 218-232.
20. Titus RG, Ceredig R, Cerrottini JC, Louis JA, 1985. Therapeutic effect of anti-L3T4 monoclonal GK 1.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice. J Immunol 135: 2108-2114.
21. Scott P, 1991. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147: 3149-3155.
22. Perez H, Arrendondo B, Gonzalez M, 1978. Comparative study of American cutaneous leishmaniasis and diffuse cutaneous leishmaniasis in two strains of inbred mice. Infect Immun 22: 301-307.
23. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL, 1986. Two types of marine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357.
24. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A, 1988. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 168: 1675-1684.
25. Morris L, Troutt AB, McLeod KS, Kelso A, Handman E, Aebischer T, 1993. Interleukin-4 but not gamma inteferon production correlates with severity of murine cutaneous leishmaniasis. Infect Immun 61: 3459-3465.
26. Afonso LC, Scott P, 1993. Immune response associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect Immun 61: 2952-2959.